164 related articles for article (PubMed ID: 38139182)
1. The Inactivation of the Putative Two-Component System Sensor PA14_27940 Increases the Susceptibility to Several Antibiotics and Reduces the Motility of
Genova R; Gil-Gil T; Cuesta T; Martínez JL; Sanz-García F
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139182
[TBL] [Abstract][Full Text] [Related]
2. Multidrug Adaptive Resistance of Pseudomonas aeruginosa Swarming Cells.
Coleman SR; Blimkie T; Falsafi R; Hancock REW
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844008
[TBL] [Abstract][Full Text] [Related]
3. Aminoglycoside resistance in
Thacharodi A; Lamont IL
J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708991
[No Abstract] [Full Text] [Related]
4. Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.
McCaughey G; Gilpin DF; Schneiders T; Hoffman LR; McKevitt M; Elborn JS; Tunney MM
Antimicrob Agents Chemother; 2013 Nov; 57(11):5406-14. PubMed ID: 23959314
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa Polynucleotide Phosphorylase Controls Tolerance to Aminoglycoside Antibiotics by Regulating the MexXY Multidrug Efflux Pump.
Fan Z; Pan X; Wang D; Chen R; Fu T; Yang B; Jin Y; Bai F; Cheng Z; Wu W
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257447
[No Abstract] [Full Text] [Related]
6. Antibiotic inducibility of the mexXY multidrug efflux operon of Pseudomonas aeruginosa: involvement of the MexZ anti-repressor ArmZ.
Hay T; Fraud S; Lau CH; Gilmour C; Poole K
PLoS One; 2013; 8(2):e56858. PubMed ID: 23441219
[TBL] [Abstract][Full Text] [Related]
7. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.
Aires JR; Köhler T; Nikaido H; Plésiat P
Antimicrob Agents Chemother; 1999 Nov; 43(11):2624-8. PubMed ID: 10543738
[TBL] [Abstract][Full Text] [Related]
8. In-vivo impact of the MexXY efflux system on aminoglycoside efficacy in an experimental model of Pseudomonas aeruginosa pneumonia treated with tobramycin.
Martha B; Croisier D; Durand D; Hocquet D; Plesiat P; Piroth L; Portier H; Chavanet P
Clin Microbiol Infect; 2006 May; 12(5):426-32. PubMed ID: 16643518
[TBL] [Abstract][Full Text] [Related]
9. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.
Muller C; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2011 Mar; 55(3):1211-21. PubMed ID: 21149619
[TBL] [Abstract][Full Text] [Related]
10. Loss of the Two-Component System TctD-TctE in
Taylor PK; Zhang L; Mah TF
mSphere; 2019 Mar; 4(2):. PubMed ID: 30842268
[TBL] [Abstract][Full Text] [Related]
11. Over-Expression of Hypochlorite Inducible Major Facilitator Superfamily (MFS) Pumps Reduces Antimicrobial Drug Susceptibility by Increasing the Production of MexXY Mediated by ArmZ in
Dulyayangkul P; Satapoomin N; Avison MB; Charoenlap N; Vattanaviboon P; Mongkolsuk S
Front Microbiol; 2020; 11():592153. PubMed ID: 33510718
[No Abstract] [Full Text] [Related]
12. An Amino Acid Substitution in Elongation Factor EF-G1A Alters the Antibiotic Susceptibility of Pseudomonas aeruginosa LasR-Null Mutants.
Abisado-Duque RG; Townsend KA; Mckee BM; Woods K; Koirala P; Holder AJ; Craddock VD; Cabeen M; Chandler JR
J Bacteriol; 2023 Jun; 205(6):e0011423. PubMed ID: 37191503
[TBL] [Abstract][Full Text] [Related]
13. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.
Mao W; Warren MS; Lee A; Mistry A; Lomovskaya O
Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215
[TBL] [Abstract][Full Text] [Related]
14. Collateral Sensitivity to Fosfomycin of Tobramycin-Resistant Mutants of
Genova R; Laborda P; Cuesta T; Martínez JL; Sanz-García F
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108055
[TBL] [Abstract][Full Text] [Related]
15. Interaction of ArmZ with the DNA-binding domain of MexZ induces expression of
Kawalek A; Modrzejewska M; Zieniuk B; Bartosik AA; Jagura-Burdzy G
Antimicrob Agents Chemother; 2019 Sep; 63(12):. PubMed ID: 31527038
[TBL] [Abstract][Full Text] [Related]
16. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED
J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the
Sanz-García F; Alvarez-Ortega C; Olivares-Pacheco J; Blanco P; Martínez JL; Hernando-Amado S
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858210
[TBL] [Abstract][Full Text] [Related]
18. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition against Pseudomonas aeruginosa.
Hamou-Segarra M; Zamorano L; Vadlamani G; Chu M; Sanchez-Diener I; Juan C; Blazquez J; Hattie M; Stubbs KA; Mark BL; Oliver A
J Antimicrob Chemother; 2017 Feb; 72(2):448-454. PubMed ID: 27999022
[TBL] [Abstract][Full Text] [Related]
20. Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction.
Jeannot K; Sobel ML; El Garch F; Poole K; Plésiat P
J Bacteriol; 2005 Aug; 187(15):5341-6. PubMed ID: 16030228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
